Products for Research Use Only

HPV16 E7 (86-93) (TFA)

CAT: 0804-HY-P1778A-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P1778A-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
HPV16 E7 (86-93) TFA is a human leukocyte antigen (HLA) -A2.1 restricted HPV16 E7-derived peptide. HPV16 E7 (86-93) TFA is immunogenic in cervical carcinomas[1][2].
UNSPSC
12352209
Target
HPV
Type
Peptides
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hpv16-e7-86-93-tfa.html
Purity
98.01
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : 6.67 mg/mL (ultrasonic)
Smiles
CC[C@H](C)[C@@H](C(O)=O)NC([C@H]1N(C([C@H](CS)NC([C@H](C(C)C)NC([C@H]([C@@H](C)CC)NC(CNC([C@H](CC(C)C)NC([C@H]([C@H](O)C)N)=O)=O)=O)=O)=O)=O)CCC1)=O.OC(C(F)(F)F)=O
Molecular Formula
C39H67F3N8O12S
Molecular Weight
929.06
References & Citations
[1]Hoffmann TK, et al. T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx. Int J Cancer. 2006 Apr 15;118 (8) :1984-91.|[2]Cheng WF, et al. Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations. Immunology. 2005 May;115 (1) :136-49.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported